Mikhaeel NG - Search Results

1

Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients.

Eertink JJ, Burggraaff CN, Heymans MW, Dührsen U, Hüttmann A, Schmitz C, Müller S, Lugtenburg PJ, Barrington SF, Mikhaeel NG, Carr R, Czibor S, Györke T, Ceriani L, Zucca E, Hutchings M, Kostakoglu L, Loft A, Fanti S, Wiegers SE, Pieplenbosch S, Boellaard R, Hoekstra OS, Zijlstra JM, de Vet HCW. Eertink JJ, et al. Among authors: mikhaeel ng. Blood Adv. 2021 May 11;5(9):2375-2384. doi: 10.1182/bloodadvances.2021004467. Blood Adv. 2021. PMID: 33944897 Free PMC article.

2

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT.

Mikhaeel NG, Timothy AR, O'Doherty MJ, Hain S, Maisey MN. Mikhaeel NG, et al. Leuk Lymphoma. 2000 Nov;39(5-6):543-53. doi: 10.3109/10428190009113384. Leuk Lymphoma. 2000. PMID: 11342337

3

Positron emission tomography in the management of lymphomas.

O'Doherty MJ, Macdonald EA, Barrington SF, Mikhaeel NG, Schey S. O'Doherty MJ, et al. Among authors: mikhaeel ng. Clin Oncol (R Coll Radiol). 2002 Oct;14(5):415-26. doi: 10.1053/clon.2002.0118. Clin Oncol (R Coll Radiol). 2002. PMID: 12555882

4

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma.

Hutchings M, Mikhaeel NG, Fields PA, Nunan T, Timothy AR. Hutchings M, et al. Among authors: mikhaeel ng. Ann Oncol. 2005 Jul;16(7):1160-8. doi: 10.1093/annonc/mdi200. Epub 2005 Jun 6. Ann Oncol. 2005. PMID: 15939713 Free article. Clinical Trial.

5

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Mikhaeel NG, Hutchings M, Fields PA, O'Doherty MJ, Timothy AR. Mikhaeel NG, et al. Ann Oncol. 2005 Sep;16(9):1514-23. doi: 10.1093/annonc/mdi272. Epub 2005 Jun 24. Ann Oncol. 2005. PMID: 15980161 Free article.

6

The role of FDG PET in the management of lymphoma: what is the evidence base?

Kirby AM, Mikhaeel NG. Kirby AM, et al. Among authors: mikhaeel ng. Nucl Med Commun. 2007 May;28(5):335-54. doi: 10.1097/MNM.0b013e3280895e23. Nucl Med Commun. 2007. PMID: 17414883 Review.

7

Interim fluorodeoxyglucose positron emission tomography for early response assessment in diffuse large B cell lymphoma: where are we now?

Mikhaeel NG. Mikhaeel NG. Leuk Lymphoma. 2009 Dec;50(12):1931-6. doi: 10.3109/10428190903275610. Leuk Lymphoma. 2009. PMID: 20001245 Review.

8

Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma.

Barrington SF, MacKewn JE, Schleyer P, Marsden PK, Mikhaeel NG, Qian W, Mouncey P, Patrick P, Popova B, Johnson P, Radford J, O'Doherty MJ. Barrington SF, et al. Among authors: mikhaeel ng. Ann Oncol. 2011 Mar;22(3):739-745. doi: 10.1093/annonc/mdq428. Epub 2010 Sep 2. Ann Oncol. 2011. PMID: 20813876 Free article.

9

Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy?

Yeoh KW, Mikhaeel NG. Yeoh KW, et al. Among authors: mikhaeel ng. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):14-20. doi: 10.1016/j.ijrobp.2012.02.023. Epub 2012 May 10. Int J Radiat Oncol Biol Phys. 2013. PMID: 22578540 Review.

10

Imaging follicular lymphoma using positron emission tomography with [(18)F]fluorodeoxyglucose: to what purpose?

Barrington SF, Mikhaeel NG. Barrington SF, et al. Among authors: mikhaeel ng. J Clin Oncol. 2012 Dec 10;30(35):4285-7. doi: 10.1200/JCO.2012.45.4082. Epub 2012 Oct 29. J Clin Oncol. 2012. PMID: 23109690 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page